Pasquale Pagliaro is an expert in Cardiology at University of Turin (Italy). As of September 2026, ScienceLeadR ranks Pasquale Pagliaro in the top 1% of experts worldwide for Reperfusion Injury. Pasquale Pagliaro has authored 305 publications, the most recent in 2026, and is an investigator in 2 clinical trials. SLR score: 919 (community average: 125). How the SLR is computed.

LeadR Profile

Pasquale Pagliaro University of Turin Italy
919 ScienceLeadR Reputation 919
Network Map

Cardiology

Subspecialties: Pharmacy - Biochemistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1991 - 2026

Source: PubMed

University of Turin

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 305

Citations

Citations: 10 166 1st author: 43 Last author: 90 Unique author: 5


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Serum from Patients with Antiphospholipid Syndrome Differentially Affects Venous and Microcirculatory Endothelial Cells.
PMID 42737893 — cells, microcirculation, serum, caspase 3, caspases, antiphospholipid syndrome, endothelial cells, therapeutics, endothelium
Biology (Basel)20260
Harnessing the novel safeguarding role of Selenoprotein T in age-related myocardial left and right decline through the ferroptosis-mitochondrial axis.
PMID 42010677 — selenoproteins, biomedical research, ferroptosis
J Transl Med20260
Empagliflozin improves metabolism and prevents myocardial and coronary dysfunction in streptozotocin-diabetic and non-diabetic rats subjected to ischemia/reperfusion.
PMID 41995817 — cells, autophagy, heart, cardiovascular system, recycling, cardiology, streptozocin, reperfusion, reperfusion injury, ischemia, plasma
Basic Res Cardiol20260
Oxidative Stress in Takotsubo Syndrome: Insights into Extracellular Vesicles and Their Potential Clinical Relevance.
PMID 41897449 — extracellular vesicles, heart failure, stress, physiological, oxidative stress, biomarkers, takotsubo cardiomyopathy
Antioxidants (Basel)20260
Insights in ischemia/reperfusion injury and cardioprotection: neglected and emerging pathways and therapeutic targets for a personalized therapy.
PMID 41826738 — cells, genes, poly(adp-ribose) polymerase inhibitors, cardiology, reperfusion, reperfusion injury, research, therapeutics, ischemia
Basic Res Cardiol20260

Clinical Studies 2

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 1
Phase 4 1

By status:

Completed 2

By type:

Interventional 1
Observational 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 1
multicentricup10 0

Main Topics

LeadR Networks

Main global connection map